Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis
about
Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectivenessAntiretroviral treatment regardless of CD4 count: the universal answer to a contextual questionSTART or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus InfectionSystematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan AfricaTB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysisHIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited SettingsSetting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa.Cryptococcal meningitis: A neglected NTD?Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up.Socioeconomic gradients in internalized stigma among 4,314 persons with HIV in sub-Saharan Africa.T-Cell Subsets Predict Mortality in Malnourished Zambian Adults Initiating Antiretroviral Therapy.A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: a prospective observational cohort study.A killer combination that must be stoppedPredictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.CD4 Counts at Entry to HIV Care in Mexico for Patients under the "Universal Antiretroviral Treatment Program for the Uninsured Population," 2007-2014Advanced HIV disease at presentation to care in Nairobi, Kenya: late diagnosis or delayed linkage to care?--a cross-sectional study.Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled TrialFactors Associated with Early Mortality in HIV-Positive Men and Women Investigated for Tuberculosis at Ethiopian Health Centers.Pathways to HIV testing and care in Goa, India: exploring psychosocial barriers and facilitators using mixed methodsBurden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: a systematic review and meta-analysis.Trends in ART Initiation among Men and Non-Pregnant/Non-Breastfeeding Women before and after Option B+ in Southern Malawi.HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda.Towards a scalable HIV cure research agenda: the role of co-infections.Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women.HIV infection and immune activation: the role of coinfections.Estimating the impact of universal antiretroviral therapy for HIV serodiscordant couples through home HIV testing: insights from mathematical models.Implementation and Operational Research: Impact of Nurse-Targeted Care on HIV Outcomes Among Immunocompromised Persons: A Before-After Study in Uganda.Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA PanelThe Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness.Beyond the 90-90-90: refocusing HIV prevention as part of the global HIV response.Cascade of Refusal-What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa?High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau - a cohort study from West Africa.Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in KenyaThe validity of the biological eligibility criteria to antiretroviral treatment in comparison to the systematic antiretroviral treatment in a cohort of people living with the HIV in the Southern Kivu Province, Democratic Republic of the Congo.Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework.Program Implementation of Option B+ at a President's Emergency Plan for AIDS Relief-Supported HIV Clinic Improves Clinical Indicators But Not Retention in Care in Mbarara, Uganda.From HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa.Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid.Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.
P2860
Q26738303-F485A9A1-0328-4D2E-91FD-805B1C433A3CQ26741384-4C445B9F-371B-4366-A554-7852BCB6D668Q26753830-1EC73A7E-E7BA-42FC-B7C3-95EC6BE810D7Q26774956-671239F0-244F-47FC-ACFC-F016AB323440Q28073480-3075DD2D-F96E-4D7D-88C6-6AAB8AFBF7D7Q28078958-35CDF079-5217-4963-B011-9EFECB7F9070Q33851741-2AC6461A-11F1-470B-81BB-7481798E55D9Q33852819-179C6843-390C-4391-860A-71C8EF9AC3FEQ33859987-26516435-0E02-4C2F-8149-1F62C60E8C1AQ35130632-0F430BE2-6E24-4633-AA58-BEC245F8CF50Q35666026-DEFEB51C-BFBE-4FA2-9844-9DCC3C0AEC28Q35684756-88E657AF-EB90-4112-BD55-EF1FB6C5F9F7Q35854996-3E2F6DB9-90DC-4E40-BBAD-751D4427577BQ35965602-40147621-832A-4117-9A0D-4330245D3F13Q35973691-C7323F13-179E-4D19-86D5-DAD3C1563553Q35993151-979507F9-D265-4D56-B011-CF4232D27229Q36013294-C33D5FAE-87EE-4DD3-ACF1-C8ECD09F96B1Q36043944-CFBEFFE2-E64A-4E3A-8527-FAD35E786AE2Q36102301-038D1995-A432-4FB8-A795-32570F11C68CQ36128774-DCDE22F9-9BDE-453B-A125-86EEF21590E0Q36230357-4A932D49-595F-49CE-9AB6-5E47C1AC389DQ36522679-C32CCB9A-18F9-411D-ABE7-37F3D0672A94Q36540033-0E493990-9710-4ECE-8887-D9F62DAC2E97Q36576629-769B690C-9D42-49AE-96B0-C7A67FF313C0Q36796783-FFFE61F9-2F99-4C12-8154-393A9FED2C98Q36897844-0F98D5FA-6436-41D8-937F-3B481CF1CE5FQ37162659-648E0548-166C-4CED-A7E0-0FDC3542432EQ37234729-3CD584FF-F558-4FDA-9853-82AA3AB9FCA4Q37235371-812B497C-E682-4DE5-B5A6-8DA3CF368A14Q37244536-53A32F18-C8F1-4E43-8E69-70F15821F57CQ37512411-D0D03ECE-B1B3-4867-9580-133A8E675A1BQ37584042-E3B56B92-4C3F-4770-BC2C-2E08E053F3A0Q37608851-BD7F1F93-5522-4BD1-A1E1-1CAE50AEA2FEQ37656281-D7EE13B9-4B4A-4303-8088-D98494A01BA2Q37666698-39192B8A-7187-4D52-87A0-551E01DC66D8Q38368637-6BD718C0-44A8-40EC-96DC-3972D35EED4FQ38400358-CF195745-42F5-4C79-8C05-400638FFA885Q38402922-6255FE5D-39AB-4257-B0CD-A6639543B87EQ38605530-2906F625-679B-48F3-909C-9C2AEF4089E6Q38662366-ADE35489-1A80-4EF0-827A-B1CC9F17353D
P2860
Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Trends in CD4 count at present ...... ca, 2002-2013: a meta-analysis
@ast
Trends in CD4 count at present ...... ca, 2002-2013: a meta-analysis
@en
type
label
Trends in CD4 count at present ...... ca, 2002-2013: a meta-analysis
@ast
Trends in CD4 count at present ...... ca, 2002-2013: a meta-analysis
@en
prefLabel
Trends in CD4 count at present ...... ca, 2002-2013: a meta-analysis
@ast
Trends in CD4 count at present ...... ca, 2002-2013: a meta-analysis
@en
P2860
P50
P356
P1476
Trends in CD4 count at present ...... ca, 2002-2013: a meta-analysis
@en
P2093
Courtney K Ng
Mark J Siedner
P2860
P304
P356
10.1093/CID/CIU1137
P407
P577
2014-12-16T00:00:00Z